Technical note: Computational study on thermal management schemes for tumor-treating fields therapy

被引:0
作者
Yang, Xin [1 ]
Hu, Chunhua [1 ]
Li, Luming [1 ,2 ,3 ]
机构
[1] Tsinghua Univ, Natl Engn Res Ctr Neuromodulat, Sch Aerosp Engn, Beijing, Peoples R China
[2] Tsinghua Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China
[3] Changping Lab, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
electrode array configuration; temperature management; TTFields therapy; ELECTRIC-FIELDS; GLIOBLASTOMA; BRAIN;
D O I
10.1002/mp.17296
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundThe study focuses on thermal management in tumor-treating fields (TTFields) therapy, crucial for patient compliance and therapeutic effectiveness. TTFields therapy, an established treatment for glioblastoma, involves applying alternating electric fields to the brain. However, managing the thermal effects generated by electrodes is a major challenge, impacting patient comfort and treatment efficiency.PurposeThis research aims to explore methods for controlling temperature increases during TTFields therapy without reducing its duty cycle. The study emphasizes optimizing electrode configurations and array arrangements to mitigate temperature rise, thereby maintaining therapy effectiveness and patient compliance.MethodsUsing a simplified multi-layer tissue model and finite element analysis, various electrode configurations and array shapes were tested in COMSOL Multiphysics v6.0. Adjustments included changing the electrode gel layer radius from 8 to 12 mm, electrode spacing, and transitioning to a more uniform array arrangement, such as a square array or a circular array.ResultsThe study revealed a strong correlation between high temperatures and edge current density distributions on electrodes. It was found that increasing the electrode gel layer's diameter, enlarging electrode spacing, and adopting a uniform array arrangement markedly mitigated temperature rises. By increasing the gel layer radius from the original 10 to 12 mm, a reduction in the peak temperature increases of approximately 0.3 degrees C was observed. Changing the layout from rectangular to circular with the same area further reduced the peak temperature rise by 0.5 degrees C. Additionally, enlarging the spacing between electrodes also contributed to temperature control. By integrating these strategies, we designed a new circular electrode array with an electrode spacing of 45 mm and a gel radius of 12 mm, successfully reducing the peak temperature from 42.1 degrees C to 40.8 degrees C, effectively achieving temperature control.ConclusionsThe research demonstrates that improving electrode and array configurations can effectively manage temperature in TTFields therapy without compromising treatment duration. This strategy is crucial as TTFields therapy relies on prolonged field exposure for effectiveness. The findings offer valuable insights into thermal management in electrode array design and could lead to enhanced patient compliance and treatment efficacy in TTFields therapy.
引用
收藏
页码:7632 / 7644
页数:13
相关论文
共 50 条
  • [31] The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
    Krigers, Aleksandrs
    Pinggera, Daniel
    Demetz, Matthias
    Kornberger, Lisa-Marie
    Kerschbaumer, Johannes
    Thome, Claudius
    Freyschlag, Christian F.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [32] Perspective on the EF-14 trial and its implications for the role of tumor-treating fields in the management of glioblastoma
    Mohan, Suyash
    Chawla, Sanjeev
    Skolnik, Aaron
    Poptani, Harish
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S272 - S275
  • [33] Effectiveness of tumor-treating fields to reduce the proliferation and migration of liposarcoma cell lines
    Lee, Won Seok
    Jang, Yoonjung
    Cho, Ahyeon
    Kim, Yu Bin
    Bu, Young Hyun
    Yang, Somi
    Kim, Eun Ho
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (02)
  • [34] Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis
    Regev, Ohad
    Merkin, Vladimir
    Blumenthal, Deborah T.
    Melamed, Israel
    Kaisman-Elbaz, Tehila
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (04) : 426 - 440
  • [35] Tumor-treating fields in combination with sorafenib restrain the proliferation of liver cancer in vitro
    Jang, Yoonjung
    Lee, Won Seok
    Sai, Sei
    Kim, Jeong Yub
    Kim, Jong-Ki
    Kim, Eun Ho
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [36] Tumor treating fields: a new frontier in cancer therapy
    Davies, Angela M.
    Weinberg, Uri
    Palti, Yoram
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012, 2013, 1291 : 86 - 95
  • [37] Tumor treating fields: a new approach to glioblastoma therapy
    Rick, Jonathan
    Chandra, Ankush
    Aghi, Manish K.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (03) : 447 - 453
  • [38] The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
    Riley, Mercedes M.
    San, Pyay
    Lok, Edwin
    Swanson, Kenneth D.
    Wong, Eric T.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (146):
  • [39] Association between conflict of interest and published position on tumor-treating fields for the treatment of glioblastoma
    Hayes, Michael J.
    Prasad, Vinay
    JOURNAL OF CANCER POLICY, 2019, 21
  • [40] Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study
    Kanamori, Masayuki
    Tsuzuki, Shunsuke
    Shibahara, Ichiyo
    Saito, Kuniaki
    Shimoda, Yoshiteru
    Tanaka, Kazuhiro
    Yamaguchi, Shigeru
    Natsumeda, Manabu
    Matsutani, Tomoo
    Hanihara, Mitsuto
    Nakada, Mitsutoshi
    Kuroda, Jun-Ichiro
    Matsuda, Masahide
    Yoshimoto, Koji
    Yonezawa, Ushio
    Sonoda, Yukihiko
    Takano, Koji
    Yonezawa, Hajime
    Otani, Yoshihiro
    Nakahara, Yukiko
    Uchida, Masashi
    Nonaka, Masahiro
    Mineharu, Yohei
    Kitamura, Yohei
    Yamashita, Shinji
    Yamauchi, Takahiro
    Miyake, Yohei
    Deguchi, Shoichi
    Beppu, Takaaki
    Tamura, Kaoru
    Koizumi, Shinichiro
    Hirose, Yuichi
    Asano, Kenichiro
    Hiruta, Ryo
    Kinoshita, Manabu
    Miyake, Keisuke
    Nakayama, Noriyuki
    Inoue, Akihiro
    Ono, Takahiro
    Sasaki, Takahiro
    Akiyama, Yukinori
    Fukami, Shinjiro
    Yoshino, Atsuo
    Kawanishi, Yu
    Asanome, Taku
    Yamaguchi, Takuhiro
    Takahashi, Masamichi
    Yamasaki, Fumiyuki
    Arakawa, Yoshiki
    Narita, Yoshitaka
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)